Literature DB >> 21959377

Rational design to improve thermostability and specific activity of the truncated Fibrobacter succinogenes 1,3-1,4-β-D-glucanase.

Jian-Wen Huang1, Ya-Shan Cheng, Tzu-Ping Ko, Cheng-Yen Lin, Hui-Lin Lai, Chun-Chi Chen, Yanhe Ma, Yingying Zheng, Chun-Hsiang Huang, Peijian Zou, Je-Ruei Liu, Rey-Ting Guo.   

Abstract

1,3-1,4-β-D-Glucanase has been widely used as a feed additive to help non-ruminant animals digest plant fibers, with potential in increasing nutrition turnover rate and reducing sanitary problems. Engineering of enzymes for better thermostability is of great importance because it not only can broaden their industrial applications, but also facilitate exploring the mechanism of enzyme stability from structural point of view. To obtain enzyme with higher thermostability and specific activity, structure-based rational design was carried out in this study. Eleven mutants of Fibrobacter succinogenes 1,3-1,4-β-D-glucanase were constructed in attempt to improve the enzyme properties. In particular, the crude proteins expressed in Pichia pastoris were examined firstly to ensure that the protein productions meet the need for industrial fermentation. The crude protein of V18Y mutant showed a 2 °C increment of Tm and W203Y showed ∼30% increment of the specific activity. To further investigate the structure-function relationship, some mutants were expressed and purified from P. pastoris and Escherichia coli. Notably, the specific activity of purified W203Y which was expressed in E. coli was 63% higher than the wild-type protein. The double mutant V18Y/W203Y showed the same increments of Tm and specific activity as the single mutants did. When expressed and purified from E. coli, V18Y/W203Y showed similar pattern of thermostability increment and 75% higher specific activity. Furthermore, the apo-form and substrate complex structures of V18Y/W203Y were solved by X-ray crystallography. Analyzing protein structure of V18Y/W203Y helps elucidate how the mutations could enhance the protein stability and enzyme activity.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959377     DOI: 10.1007/s00253-011-3586-7

Source DB:  PubMed          Journal:  Appl Microbiol Biotechnol        ISSN: 0175-7598            Impact factor:   4.813


  6 in total

1.  Crystallization and preliminary X-ray diffraction analysis of an endo-1,4-β-D-glucanase from Aspergillus aculeatus F-50.

Authors:  Yun Chen; Jian Wen Huang; Chun Chi Chen; Hui Lin Lai; Jian Jin; Rey Ting Guo
Journal:  Acta Crystallogr F Struct Biol Commun       Date:  2015-03-20       Impact factor: 1.056

2.  Enhancing human spermine synthase activity by engineered mutations.

Authors:  Zhe Zhang; Yueli Zheng; Margo Petukh; Anthony Pegg; Yoshihiko Ikeguchi; Emil Alexov
Journal:  PLoS Comput Biol       Date:  2013-02-28       Impact factor: 4.475

3.  The substrate/product-binding modes of a novel GH120 β-xylosidase (XylC) from Thermoanaerobacterium saccharolyticum JW/SL-YS485.

Authors:  Chun-Hsiang Huang; Yu Sun; Tzu-Ping Ko; Chun-Chi Chen; Yingying Zheng; Hsiu-Chien Chan; Xuefei Pang; Juergen Wiegel; Weilan Shao; Rey-Ting Guo
Journal:  Biochem J       Date:  2012-12-15       Impact factor: 3.857

4.  Engineering the conserved and noncatalytic residues of a thermostable β-1,4-endoglucanase to improve specific activity and thermostability.

Authors:  Xiutao Chen; Weiguang Li; Peng Ji; Yang Zhao; Chengyao Hua; Chao Han
Journal:  Sci Rep       Date:  2018-02-13       Impact factor: 4.379

5.  Improvement of the catalytic activity and thermostability of a hyperthermostable endoglucanase by optimizing N-glycosylation sites.

Authors:  Chao Han; Qunqing Wang; Yanxu Sun; Ruirui Yang; Mengyu Liu; Siqi Wang; Yifan Liu; Lifan Zhou; Duochuan Li
Journal:  Biotechnol Biofuels       Date:  2020-02-26       Impact factor: 6.040

Review 6.  From protein engineering to immobilization: promising strategies for the upgrade of industrial enzymes.

Authors:  Raushan Kumar Singh; Manish Kumar Tiwari; Ranjitha Singh; Jung-Kul Lee
Journal:  Int J Mol Sci       Date:  2013-01-10       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.